Convalescent Plasma Lowered Risk of Death in COVID-19 ARDS
- PMID: 37938859
- DOI: 10.1001/jama.2023.21872
Convalescent Plasma Lowered Risk of Death in COVID-19 ARDS
Similar articles
-
Convalescent plasma for COVID-19 complicated by ARDS due to TRALI.BMJ Case Rep. 2021 Jan 28;14(1):e239762. doi: 10.1136/bcr-2020-239762. BMJ Case Rep. 2021. PMID: 33509890 Free PMC article.
-
Convalescent plasma for pediatric patients with SARS-CoV-2-associated acute respiratory distress syndrome.Pediatr Blood Cancer. 2020 Nov;67(11):e28693. doi: 10.1002/pbc.28693. Epub 2020 Sep 4. Pediatr Blood Cancer. 2020. PMID: 32885904 Free PMC article.
-
Efficacy and safety of convalescent plasma therapy in severe COVID-19 patients with acute respiratory distress syndrome.Int Immunopharmacol. 2021 Apr;93:107239. doi: 10.1016/j.intimp.2020.107239. Epub 2020 Dec 2. Int Immunopharmacol. 2021. PMID: 33582019 Free PMC article. Clinical Trial.
-
Convalescent Plasma Therapy for COVID-19: Lessons from SARS-CoV, MERS-CoV, and H1N1 Infection.Acta Med Indones. 2021 Jan;53(1):86-95. Acta Med Indones. 2021. PMID: 33818411 Review.
-
COVID-19: benefits and risks of passive immunotherapeutics.Hum Vaccin Immunother. 2020 Dec 1;16(12):2963-2972. doi: 10.1080/21645515.2020.1808410. Epub 2020 Sep 22. Hum Vaccin Immunother. 2020. PMID: 32962524 Free PMC article. Review.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
